SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
五十
Lv6
2440 积分
2022-09-28 加入
最近求助
最近应助
互助留言
Tenascin C+ papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis
7天前
已完结
Intragenic β-synuclein rearrangements in malignancy
1个月前
已完结
Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10
1个月前
已完结
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
1个月前
已完结
Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study
1个月前
已完结
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181
1个月前
已完结
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-181
1个月前
已关闭
Pembrolizumab in Asian patients with microsatellite‐instability‐high/mismatch‐repair‐deficient colorectal cancer
1个月前
已完结
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*
1个月前
已完结
First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
2个月前
已完结
没有进行任何应助
已找到【积分已退回】
1个月前
没有应助【积分已退回】
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论